Regulations Governing the Acquisition and Disposal of Assets by Public Companies Article 21
Where a public company engaging in derivatives trading, its board of directors shall faithfully supervise and manage such trading in accordance with the following principles:1. Designate senior management personnel to pay continuous attention to monitoring and controlling derivatives trading risk.2. Periodically evaluate whether derivatives trading performance is consistent with established operational strategy and whether the risk undertaken is within the company's permitted scope of tolerance.Senior management personnel authorized by the board of directors shall manage derivatives trading in accordance with the following principles:1. Periodically evaluate the risk management measures currently employed are appropriate and are faithfully conducted in accordance with these Regulations and the procedures for engaging in derivatives trading formulated by the company.2. When irregular circumstances are found in the course of supervising trading and profit-loss circumstances, appropriate measures shall be adopted and a report immediately made to the board of directors; where a company has independent directors, an independent director shall be present at the meeting and express an opinion.A company shall report to the soonest meeting of the board of directors after it authorizes the relevant personnel to handle derivates trading in accordance with its Procedures for Engaging in Derivatives Trading.
中文原文 公開發行公司取得或處分資產處理準則第21條
公開發行公司從事衍生性商品交易，董事會應依下列原則確實監督管理：
一、指定高階主管人員應隨時注意衍生性商品交易風險之監督與控制。
二、定期評估從事衍生性商品交易之績效是否符合既定之經營策略及承擔之風險是否在公司容許承受之範圍。
董事會授權之高階主管人員應依下列原則管理衍生性商品之交易：
一、定期評估目前使用之風險管理措施是否適當並確實依本準則及公司所定之從事衍生性商品交易處理程序辦理。
二、監督交易及損益情形，發現有異常情事時，應採取必要之因應措施，並立即向董事會報告，已設置獨立董事者，董事會應有獨立董事出席並表示意見。
公開發行公司從事衍生性商品交易，依所定從事衍生性商品交易處理程序規定授權相關人員辦理者，事後應提報最近期董事會。
一、指定高階主管人員應隨時注意衍生性商品交易風險之監督與控制。
二、定期評估從事衍生性商品交易之績效是否符合既定之經營策略及承擔之風險是否在公司容許承受之範圍。
董事會授權之高階主管人員應依下列原則管理衍生性商品之交易：
一、定期評估目前使用之風險管理措施是否適當並確實依本準則及公司所定之從事衍生性商品交易處理程序辦理。
二、監督交易及損益情形，發現有異常情事時，應採取必要之因應措施，並立即向董事會報告，已設置獨立董事者，董事會應有獨立董事出席並表示意見。
公開發行公司從事衍生性商品交易，依所定從事衍生性商品交易處理程序規定授權相關人員辦理者，事後應提報最近期董事會。